Glucagon-like peptide-1 Receptor Agonists and Gastrointestinal Adverse Events: a Systematic Review and Meta-analysis [0.03%]
葡萄糖依赖性胰岛素释放肽受体激动剂和胃肠道不良反应：系统评价和meta分析
Cho-Hung Chiang,Aunchalee Jaroenlapnopparat,Sena Cakir Colak et al.
Cho-Hung Chiang et al.
Background and aims: Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are widely used for glycemic control or weight management in patients with type 2 diabetes mellitus (T2DM) or overweight/obesity.
Comparison of the prognostic value of different arterial sites atherosclerosis risk markers for development of Macro- and microvascular complications in individuals with type 2 diabetes: The Rio de Janeiro type 2 diabetes cohort study [0.03%]
不同类型动脉粥样硬化风险标志物预测糖代谢异常个体大、微血管并发症发生价值的队列研究：里约热内卢2型糖尿病人群队列研究结果
Claudia R L Cardoso,Nathalie C Leite,Alan C de Souza et al.
Claudia R L Cardoso et al.
Methods: In a prospective cohort of 479 individuals with type 2 diabetes followed-up for 12 years, the 3 biomarkers were measured at baseline.
Methylglyoxal-induced RNA modifications decrease RNA stability and translation and are associated with type 2 diabetes [0.03%]
甲基乙二醛引起的RNA修饰降低了RNA稳定性和蛋白质表达并其与2型糖尿病有关
Edwin De Jesus Lopez Gonzalez,Seigmund Wai Tsuen Lai,Kelani Sun et al.
Edwin De Jesus Lopez Gonzalez et al.
MG-adducts on DNA and protein have been well characterized and are associated with type 2 diabetes (T2D) and related complications.
Differences between Type 2 Diabetes Mellitus and Obesity Management: Medical, Social, and Public Health Perspectives [0.03%]
从医学、社会和公共卫生角度分析2型糖尿病和肥胖的差异性管理措施
Soo Lim,Ga Eun Nam,Arya M Sharma
Soo Lim
Obesity and type 2 diabetes mellitus (T2DM) are among the most urgent global public health challenges, yet differ markedly in recognition and management across medical, social, infrastructure, and policy domains.
Thermogenesis and reduced lipid synthesis: one-anastomosis gastric bypass bariatric surgery 6-month follow ups in adipose tissue context for type 2 diabetes [0.03%]
一种胃旁路手术6个月随访：糖尿病患者脂肪组织中的生热作用和脂质合成减少
I Stafeev,M Agareva,S Michurina et al.
I Stafeev et al.
Background: One-anastomosis gastric bypass (OAGB) represents a novel less invasive bariatric surgery technique which can significantly improve systemic metabolism and adipose tissue health in type 2 diabetes mellitus (T2DM) patients.
Mucosal-associated invariant T cells in diabetes mellitus: Protective or destructive? [0.03%]
黏膜相关不变T细胞在糖尿病中：保护作用还是破坏作用？
Mahvash Sadeghi,Sajad Dehnavi,Amir Mohammad Amiri et al.
Mahvash Sadeghi et al.
Diabetes mellitus (DM) is a chronic metabolic condition that can be categorized into two major subsets, type 1 diabetes mellitus (T1DM) and type 2 diabetes mellitus (T2DM).
The effect of flaxseed supplementation on anthropometric indices, blood pressure, and lipid profile in diabetic patients: A GRADE-assessed systematic review and meta-analysis of randomized controlled trials [0.03%]
评价亚麻籽补充剂对糖尿病患者体质指数、血压和血脂影响的系统综述和meta分析：基于GRADE评估
Vali Musazadeh,Shokufeh Nezamoleslami,Amir Hossein Faghfouri et al.
Vali Musazadeh et al.
Conclusion: Flaxseed supplementation effectively reduces anthropometric indices and triglyceride levels in individuals with type 2 diabetes but does not suggest any benefit on blood pressure and other lipid profile parameters.
Design, synthesis, and biological evaluation of long-acting glucagon-like peptide-1 (GLP-1) conjugates modified with dual fatty acids and a proline-alanine-serine (PAS) polypeptide [0.03%]
双脂肪酸和脯氨酸-丙氨酸-丝氨酸(PAS)多肽修饰的长效胰高血糖素样肽-1(GLP-1)缀合物的设计、合成及生物评价
Chengcheng Wang,Jinhua Zhang,Yuanzhen Dong et al.
Chengcheng Wang et al.
The increasing prevalence of type 2 diabetes presents a major global health challenge. Glucagon-like peptide-1 (GLP-1) receptor agonists offer glycemic control, weight loss, and cardiovascular benefits but are limited by rapid enzymatic degradation and short half-life.
Association between hypoglycaemic drug de-intensification, mortality and hospital admission in older adults with type 2 diabetes: a cohort study emulating a target trial [0.03%]
降糖药物减档与老年2型糖尿病患者的死亡和住院风险：一项拟靶试验的队列研究
Antoine Christiaens,Alexis Cochard,Florence Tubach et al.
Antoine Christiaens et al.
Background: Hypoglycaemic drugs (sulfonylureas, glinides or insulins) are commonly prescribed for older adults with type 2 diabetes (T2D) but may carry risks of adverse events.
Bullous pemphigoid associated with vildagliptin in an elderly adult with diabetes mellitus. First case in Peru [0.03%]
与西格列汀相关的老年糖尿病患者大疱性类天疱疮一例报告
Marcio Concepción-Zavaleta,Cristian D Armas,Juan Eduardo Quiroz-Aldave et al.
Marcio Concepción-Zavaleta et al.
Vildagliptin, a dipeptidyl peptidase-4 inhibitor (DPP-4i) used in the treatment of type 2 diabetes mellitus (DM2), stands out for its safety in older adults. However, it is associated with adverse reactions, such as bullous pemphigoid (BP), although no cases have been documented in Peru to date.
耗时 0.63426 秒，为您在
48206918
条记录里面共找到 10000 篇文章 [XML]